News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
Views & Analysis A true story: Living with AIDS A 50-year-old man relates his personal experience of living with the condition.
News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News NICE review sparks new call for HIV prophylaxis NICE review backs case for Truvada pre-exposure prophylaxis, say campaigners.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
![iStock-497484764 [Converted]](https://pharmaphorum.com/wp-content/uploads/2016/11/world-aids-day-image.jpg)
